Naturally existing isoforms of miR-222 have distinct functions by Yu, F. et al.




Feng Yu, Katherine A. Pillman, Corine T. Neilsen, John Toubia, David M. Lawrence, Anna Tsykin, 
Michael P. Gantier, David F. Callen, Gregory J. Goodall and Cameron P. Bracken 
Naturally existing isoforms of miR-222 have distinct functions 
Nucleic Acids Research, 2017; 45(19):11371-11385 
The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research. This is 
an Open Access article distributed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 




























Published online 11 September 2017 Nucleic Acids Research, 2017, Vol. 45, No. 19 11371–11385
doi: 10.1093/nar/gkx788
Naturally existing isoforms of miR-222 have distinct
functions
Feng Yu1, Katherine A. Pillman1,2, Corine T. Neilsen3, John Toubia1,2, David M. Lawrence1,2,
Anna Tsykin1,2, Michael P. Gantier4,5, David F. Callen6, Gregory J. Goodall1,6,* and Cameron
P. Bracken1,6,*
1Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA 5000, Australia, 2ACRF
Cancer Genomics Facility, Centre for Cancer Biology, SA Pathology, Adelaide, SA 5000, Australia, 3School of Health,
Medical and Applied Sciences, Central Queensland University, Queensland 4000, Australia, 4Centre for Innate
Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia,
5Department of Molecular and Translational Science, Monash University, Clayton, Victoria 3168, Australia and
6School of Medicine, Discipline of Medicine, University of Adelaide, SA 5000, Australia
Received May 08, 2017; Revised July 25, 2017; Editorial Decision August 09, 2017; Accepted August 31, 2017
ABSTRACT
Deep-sequencing reveals extensive variation in the
sequence of endogenously expressed microRNAs
(termed ‘isomiRs’) in human cell lines and tissues,
especially in relation to the 3′ end. From the im-
munoprecipitation of the microRNA-binding protein
Argonaute and the sequencing of associated small
RNAs, we observe extensive 3′-isomiR variation, in-
cluding for miR-222 where the majority of endoge-
nously expressed miR-222 is extended by 1–5 nt
compared to the canonical sequence. We demon-
strate this 3′ heterogeneity has dramatic implications
for the phenotype of miR-222 transfected cells, with
longer isoforms promoting apoptosis in a size (but
not 3′ sequence)-dependent manner. The transfec-
tion of longer miR-222 isomiRs did not induce an in-
terferon response, but did downregulate the expres-
sion of many components of the pro-survival PI3K-
AKT pathway including PIK3R3, a regulatory subunit
whose knockdown phenocopied the expression of
longer 222 isoforms in terms of apoptosis and the
inhibition of other PI3K-AKT genes. As this work
demonstrates the capacity for 3′ isomiRs to medi-
ate differential functions, we contend more attention
needs to be given to 3′ variance given the prevalence
of this class of isomiR.
INTRODUCTION
MicroRNAs post-transcriptionally regulate the expression
of genes by acting as sequence-specific guides, bringing
effector proteins of the RNA-induced silencing complex
(RISC) in proximity to target mRNAs where they suppress
gene expression through a combination of translational in-
hibition and RNA destabilization (1). Typically, miRNAs
are annotated as a single defined sequence, though many
recent RNA sequencing studies (2–20) demonstrate miR-
NAs are actually expressed as a range of naturally occur-
ring variants, termed ‘isomiRs’ (21). In the conventional
biogenesis pathway, miRNA 5′ and 3′ ends are defined by
the activities of the RNAses Drosha and Dicer, which can
cause heterogeneity in length if cleavage occurs at variable
positions. Factors such as secondary structure of the pre-
cursor miRNA, sequence around cleavage sites and the in-
fluence of accessory proteins can all modulate cleavage lo-
cation (22–25). Length heterogeneity can also arise from
the ‘nibbling’ activities of exonucleases (26–29). Both of
these mechanisms result in ‘templated isomiRs’ where the
sequence of the mature miRNA matches the genomically
encoded sequence. Non-templated isomiRs (where the ma-
ture sequence differs from the genome) can arise from the
post-transcriptional addition of nucleotides (primarily A
and U) to the 3′ termini or, less commonly, from the ac-
tivities of RNA editing enzymes (21).
The majority of endogenous mature miRNA sequences
are in fact isomiRs that differ from the canonical se-
quence annotated in the miRNA sequencing repository,
miRbase (30). Interestingly, the relative abundance of dif-
ferent isomiRs can vary between tissue and developmental
stages (20,31), race and gender (14,32), pathogen exposure
(6,16) or diseases including pre-eclampsia (7), alzheimer’s
(33) and cancer (13,18,34). Heterogeneity at the 5′ end is ex-
pected to have functional consequences because it results in
‘seed-shifting’, whereby the target-specifying seed region (nt
2–8) is altered, thereby changing the expected pool of target
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genes. Although functional consequences of seed-shifting
have been demonstrated (9,10,12,17,18,35–37), the occur-
rence of 5′ variation is relatively rare. Far more common is
3′ heterogeneity, which has been shown to be of functional
consequence with non-templated 3′ adenylation and uridy-
lation having been linked tomiRNA stability (27,38–40) (so
called ‘tailing and trimming’). However, despite its frequent
occurrence, there are few reports in which the functional
consequence of templated 3′ variation have been assessed.
In this study, we catalogued endogenous length varia-
tion across breast cancer tumour samples and cell lines,
and observed the frequent occurrence of templated 3′
isomiRs. We selected the 3′ variants of miR-222 for further
study and found that the longer miR-222 isomiRs elicit a
progressively more-pronounced apoptotic phenotype that
is not attributable to the induction of an interferon re-
sponse. Instead, we found that members of the pro-survival
PI3K/AKT signalling pathway are differentially regulated
by differentmiR-222 isomiRs.We also found that longer en-
dogenous miRNAs, including longer miR-222 isomiRs, are
more nuclear enriched than shorter forms. Due to the abun-
dance of multiple endogenous miRNAs of longer size (≥24
nt) (10), these observations are likely to have wider conse-
quence beyond miR-222 and suggest consideration should




MCF10A (breast epithelial), MDA-MB-468,MCF7, T47D
(breast cancer) and KGN (granulosa) cells were purchased
from the ATCC (American Type Culture Collection). All
cell lines were subjected to regular mycoplasma moni-
toring every 1–2 months using a MycoAlert mycoplasma
detection kit (Lonza). MCF10A cells were cultured in
DMEM/F12 medium (Sigma-Aldrich) supplemented with
5% horse serum (Invitrogen, Grand Island, NY, USA), 20
ng/ml EGF, 0.5 l/ml Hydrocortisone, 100 ng/ml Cholera
toxin, 10 g/ml Insulin (Sigma-Aldrich). MB231, MB468
and KGN cell lines were cultured in Dulbecco’s modified
Eagle’smedium (DMEM) (Sigma-Aldrich), whereasMCF7
and T47D were cultured in RPMI-1640 (Sigma-Aldrich),
both supplemented with 10% (v/v) fetal calf serum (Invit-
rogen). All media were supplemented with 2 mmol/l L-
Glutamine, 100 IU/ml penicillin and 100g/ml strepto-
mycin. All cell lines were cultured at 37◦C in 5% CO2.
miRNA and siRNA overexpression and inhibition
For miRNA overexpression studies, cells were seeded at
2.5 × 105 cells/well in 6-well plates or 0.5 × 105 cells/well
in 24-well plates. Reverse-transfections were performed ac-
cording tomanufacturer’s instructions using Lipofectamine
RNAiMAX (Invitrogen) and miRVana (Ambion, Grand
Island, NY, USA) or Genepharma (Genepharma, Shang-
hai, China) miRNA mimics (20 nM), paired with nega-
tive control RNAs from the samemanufacturers. Cells were
harvested 72 h post-transfection, unless otherwise speci-
fied. Single-stranded miRNA mimics were obtained from
Genepharma and transfected at 200 nM following the same
procedure.
2′-Oxymethelated siRNAs and paired negative controls
were purchased from Genepharma, and transfected follow-
ing the same procedure (50 nM).
siPIK3R3: CAACCUCGUUUCCUUACAAAU.
Luciferase assay
Target 3′UTRs were cloned downstream of Renilla
luciferase in the psiCHECK2 dual-luciferase vector
(Promega). The Firefly luciferase gene expressed from the
same vector was used as an internal reference. Approxi-
mately 0.5 × 105 MCF10A cells were plated in each well of
24-well plates. After 24 h, psiCHECK2 vectors (nM) were
co-transfected with 10 nM miRNA mimics (or negative
control RNA), using Lipofectamine 2000 (Invitrogen)
following the manufacturer’s instructions. Cells were har-
vested 72 h post-transfection and assessed using a GloMax
20/20 Luminometer (Promega). A ratio of Renilla/Firefly
luminescence intensity was used to calculate the relative
luciferase expression activity.
Immunoblotting and antibodies
Cells were rinsed with phosphate-buffered saline (PBS)
and lysed in lysis buffer (50 mmol/l Tris–HCl, pH 7.5,
250 mmol/l NaCl, 1% Triton X-100 and 1× protease
inhibitors––Roche) on ice for 30 min. Insoluble compo-
nents of cell lysates were removed by centrifugation (12
000 g for 10 min at 4◦C) and protein concentration mea-
sured using a bicinchoninic acid protein assay kit (Pierce).
Proteins were resolved using Sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) on 8–15%
polyacrylamide gels, depending on the molecular weights
of the target proteins and transferred to a Hybond- C Ex-
tra nitrocellulose membrane (GE Healthcare Life Sciences,
Pittsburgh, PA, USA). The membrane was then blocked for
30 min in blocking buffer, made by dissolving 5% skimmilk
in TBST (50 mM Tris–HCl, 150 mM NaCl, 0.05% Tween
20, pH = 7.6).
For quantification, the following proteins were probed
in blocking buffer at 1:1000 - p53 (Santa Cruz sc-126),
p21waf1/cip1 (Cell Signalling Technology #2947), PI3K
p55 (CST #11889), phospo-Akt (CST #4051), Akt (CST
#9272), PARP (CST #9542) and Casp3 (CST #9662).
Puma (ProSci #41232) and BCL-xL (CST #2762) were
probed at 1:500 and 1:1000. Equal loading was confirmed
by using -actin (Sigma-Aldrich #AC-15) or -tubulin
(Abcam ab6046), both at 1:2000. Chemiluminescent de-
tection of protein was conducted using appropriate sec-
ondary antibodies conjugated with horseradish peroxidise
(GE Healthcare) and the enhanced chemiluminescence kit
(GE Healthcare) according to the manufacturer’s instruc-
tions.
RNA extraction and real-time PCR
RNA (>250 nt) was extracted from cells using a GenElute™
mRNA Miniprep Kit (Sigma) with on-column RNase-
free DNase digestion (Sigma). Total RNA, including small
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RNAs, was extracted using Trizol (Invitrogen) as per man-
ufacturer instruction. RNA was quantitated using a ND-
1000 NanoDrop spectrometer (Thermo Scientific). There-
after, 1g of total RNAwas reverse-transcribed into cDNA
using Moloney Murine Leukaemia Virus Reverse Tran-
scriptase (Promega) with random 6′mer primers (Promega).
Real-time polymerase chain reaction (PCR) was performed
on a CFX Connect Real-time PCR Detection System (Bio-
Rad) using a QuantiTect SYBR Green PCR Kit (QIA-
GEN). RT-PCR program: 1 × 95◦C, 3 min/40× (95◦C,
10 s/57◦C 60 s). For quantification of small RNAs, Taq-
Man gene expression assays (Applied Biosystems) were
performed following manufacturer’s instructions. The 18 s
rRNA was used for normalization.
Incucyte scanning and cell proliferation assay
Cells were plated in 24 or 96 well trays, reverse-transfected
then scanned over 72 h by Incucyte (Essen BioScience). For
proliferation assays, cells were reverse-transfected then cell
numbers measured over various time points using either
a CyQUANT proliferation kit (Invitrogen) or CellTiter 96
Aqueous MTS proliferation assay kit (Promega) according
to manufacturer’s instructions.
Cell cycle assay, viability assay and flow cytometry
Cell cycle assay was performed using PI (propidium iodide)
staining and flow cytometry. Briefly, cells were harvested,
fixed in ice-cold ethanol (70%), and incubated overnight at
4◦C. Cells were then stained with PI solution (50 g/ml;
Sigma-Aldrich) and 100 g/ml RNase A (Sigma-Aldrich)
for 45 min at 37◦C. DNA content was determined using a
FACS Calibur flow cytometer with cell cycle profiles anal-
ysed by FLOWJO software.
Cell viability assay was performed using 7AAD (7-
aminoactinomycin D) staining. Briefly, cells were harvested
72 h post-treatment, centrifuged at 1300× g, washed in PBS
and stained with 7AAD solution (2 g/ml) (Invitrogen) for
10 min at room temperature. Viable cells were determined
by flow cytometry as above.
Nuclear fractionation
Nuclear/cytoplasmic fractionation was performed using a
PARIS kit (Ambion). To enable small RNA purification,
after fractionation the lysates were mixed with 5× volume
of Trizol (Invitrogen) and total RNA extracted following
manufacturer instruction.
RNA deep sequencing and HITS-CLIP (high-throughput se-
quencing of crosslinked and immunoprecipitated RNA)
MDA-MB-231 cells (20 × 10 cm dishes) were suspended
in ice-cold PBS and crosslinked with UV at 254 nM
(Stratalinker). Cell pellets were lysed (0.1% SDS, 0.5% de-
oxycholate, 0.5% NP-40 with protease inhibitors, Roche)
for 10 min on ice followed by RQ1 DNAse (Promega) at
37◦C for 15 min with shaking. RNAse A/T1 (Ambion)
was then added for a further 8 min, prior to the addi-
tion of ethylenediaminetetraacetic acid (EDTA) (30 mM).
Pellets were then spun (30 000 rpm) and the lysate sub-
jected to immunoprecipitation for 2 h with a pan-anti-
Ago antibody (2A8) conjugated to protein-A dynabeads
(Invitrogen) using bridging rabbit anti-mouse IgG (Jack-
son Immunolabs). Pellets were then successively washed
(0.1% SDS, 0.5% deoxycholate, 0.5% NP40 in 1 × PBS;
0.1% SDS, 0.5% deoxycholate, 0.5% NP40 in 5xPBS; 50
mM Tris pH 7.5, 10 mMMgCl2, 0.5% NP40) and on-bead
phosphatase treatment performed for 30 min with antarc-
tic phosphatase (New England Biolabs) in the presence of
superasin RNAse inhibitor (Ambion). The 3′ RNA linker
(CAGACGACGAGCGGG) was labelled with P32 using
T4-PNK (NEB) and ligated on-bead for 1 h at 16◦C with
T4 RNA ligase (Fermentas). Beads were then washed as
previous and treated with T4 Polynucleotide kinase to lig-
ate the 5′ RNA linker (AGGGAGGACGAUGCGGxxxG,
with ‘X’ representing different nucleotides for barcoding).
Beads were resuspended in 4× Lithium dodecyl sulfate
Novex loading buffer with 4% B-mercaptoethanol, incu-
bated at 70◦C for 10 min and the supernatant loaded on
Novex NuPAGE 4–12% Bis-Tris acrylamide gels (Biorad).
After running, the Ago–RNA complexes were then trans-
ferred to nitrocellulose and exposed to film at −80◦C for 3
days. Complexes running at ∼110 kDa (AGO + miRNA)
and ∼130 kDa (AGO + mRNA fragments) were then ex-
cised with a scalpel and resuspended (100 mM Tris pH
7.5, 50 mM NaCl, 10 mM EDTA, 4 mg/ml proteinase K)
for 20 min at 37◦C. The sample was incubated for an ad-
ditional 20 min in the presence of 3.5 M urea and RNA
isolated by a phenol–chloroform extraction. Sample was
then run on a 10% denaturing (1:19) polyacrylamide gel
and exposed to film with an intensifying screen at −80◦C
for 5 days. Thin bands corresponding to the Ago-miRNA
(∼110 kD) and AGO mRNA fragments (∼130 kDa) were
excised, crushed and eluted at 37◦C for 1 h (1MNaOAc, pH
5.2, 1 mM EDTA). RNA was then precipitated overnight
with ethanol, centrifuged and dried. RNA was then re-
suspended in 8 l H2O, primer added (TCCCGCTCGT
CGTCTG) and reverse transcription performed using Su-
perScriptIII (Invitrogen). PCR was then performed with
the above primer and an additional primer (ACGGAGGA
CGATGCGG) for 25 cycles. PCR product was then run
on a 10% native (1:29) polyacrylamide gel, stained with
Sybr Gold (Qiagen) and bands excised over a UV light
box. The DNA was then precipitated using isopropanol




tions were then run on 2% metaphor agarose/Tris-Borate-
EDTA gels and bands (∼115 and ∼135 bp) excised corre-
sponding to the linker sequence + RNA CLIP tag. Sam-
ples were finally purified using quick-spin columns (Qiagen)
and subjected to Illumina sequencing. In house Perl scripts
were then used to filter reads for quality, trimmed of linker
sequence, separated by barcode and aligned to the human
genome using bowtie.
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Immunofluorescence
MCF10A cells adhered to Thermanox coverslips (Nalge
Nunc) were fixed in 4% PFA (paraformaldehyde) for 15 min
then blocked in 2%BSA (bovine serum albumin) for 30min.
Primary antibodies (-actin and -tubulin) were added to
cells overnight at 4◦C, 1:500 dilution. Secondary antibodies
(goat anti-Mouse Alexa Fluor 488 IgG and goat anti-rabbit
Alexa Fluor 594 IgG) (Invitrogen), also at 1:500 were incu-
bated for 1 h. Coverslips were mounted in Vectasheld An-
tifade Mounting Medium with DAPI (4′,6-Diamidino-2-
Phenylindole, Dihydrochloride) (Vector Laboratories) and
visualized using laser confocal microscopy.
Statistical analysis
Results are given as mean of at least three independent ex-
periments ± standard deviation. Student’s t-test was per-
formed using replicate values to indicate significance. Val-
ues of P < 0.05 were considered statistically significant (as
labelled with ** in figures), while values of P < 0.1 were in-
dicated by *.
RESULTS
Endogenous expression of miR-222 isoforms
Prompted by reports that numerous miRNAs exist as
length-differing isomiRs, we examined the degree of isomiR
heterogeneity of Ago-bound miRNAs in MDA-MB-231
(and SHEP) cells and noticed in particular that miR-222,
(which is abundant in these cells) hadmarked length hetero-
geneity at the 3′ end (Figure 1A). In fact most endogenous,
AGO-boundmiR-222 differed from the canonical miRBase
definition with the majority of miR-222 isomiRs extended
by between 2 and 4 nt at the 3; end. The 3′extension of
CUCU corresponds to the natural sequence within the pri-
miR, consistent with the variation in length being created
by alternative sites of cleavage by Drosha.
To assess whether this heterogeneity is a general feature
of miR-222, and not a quirk of the MDA-MB-231 cell line,
we examined the heterogeneity ofmiR-222 in other cell lines
(Figure 1B) and again found marked heterogeneity in each
dataset. To compare the length heterogeneity of miR-222
to that of miRNAs in general, we plotted the cumulative
length distributions of miRNAs inMDA-MB-231 cells and
TCGA data (Figure 1C and D) and observed that 3′ length
heterogeneity, but not 5′ heterogeneity, is a common feature
of miRNAs, as has been previously reported.
miR-222 isoforms significantly alter cell morphology
The fact that the most abundant forms of miR-222 are not
the canonical form specified in miRbase raises the possibil-
ity that experiments performed in the past using miRNA
mimics to examine the functions of miR-222 may have
used an isomiR that is not the predominant form. Mind-
ful of the fact that the literature contains conflicting con-
clusions regarding the functions of miR-222 (41–50), we
decided to examine the effects of transfecting cells with
each isoform. To investigate potential biological roles, we
transfected miRNA mimics that match endogenous miR-
222 isoforms from 21 to 25 nt in length, along with size-
matched negative control RNAs (nc21 and nc25). Cells
transfected with the larger isoforms displayed morpholog-
ical alteration, adopting a rounded phenotype ∼48 h post-
transfection, followed by blebbing and shrinkage at ∼72–
96 h post-transfection (Figure 2). These effects were pro-
gressively more severe with the transfection of larger miR-
222 isoforms. Nomorphological changes were seen with the
transfection of either 21 or 25 nt scrambled controls (Figure
2A and Supplementary Figure S1). To ascertain if this was
specific to the sequence of the 3′ extension, the 3′ end was
mutated from CUCU to GAGA (miR-222GAGA), which
caused similar morphological changes in MCF10A cells to
the endogenous sequence (Figure 2B). Length-dependent,
sequence-independent effects were further confirmed by the
transfection of additional miR-222 mimics possessing addi-
tional, non-physiological 3′ extensions (SupplementaryFig-
ure S2).We therefore conclude that the changes inmorphol-
ogy are not due to the exact sequence of the 3′ extension,
but occur in response to length. Further investigation re-
vealed the effects of longer miR-222 isomiRs are not re-
stricted to MCF10A cells, but are also present in multiple
other cell lines including KGN,MDA-MB-468, MCF7 and
T47D cells (Figure 2C).
The miR-222 isomiRs all inhibit proliferation and canonical
target gene expression
To further investigate the biological function of miR-222
isoforms, each of the four variants (21–25 nt in size) were
transfected into MCF10A cells and proliferation (and/or
migration) was assessed by confluence (Incucyte), cell count
(Cyquant), viability (MTS assay) and scratch wound clo-
sure assay (Figure 3A–D). All miR-222 isomiRs effec-
tively suppressed proliferation, withmiR-222CUCUhaving
the strongest effects (Figure 2A). Consistent with a gener-
ally anti-proliferative effect, both miR-222 and 222CUCU
(but not nc21 and nc25), also induced the expression of
CDKN1A (p21), a universal inhibitor of cyclin kinases
and mediator of cell cycle delay (51), at both the mRNA
and protein level (Figure 3E). Together, these data indi-
cate all isomiRs of miR-222 play anti-proliferative roles in
MCF10A cells.
MiRNAs function through the post-transcriptional sup-
pression of target mRNAs, typically interacting with the
3′UTR of targets via their 5′ seed sequence, though internal
and 3′ sequences may also confer target selection in some
circumstances (52). To test whether 3′UTR extension alters
targeting potential, 3′UTRs of 25 strongly predicted miR-
222 targets were cloned downstream of luciferase reporters
and the potential for differential targeting investigated with
co-transfection of either miR-222, the 3′-CUC isomiR or
the nc21 and nc25 negative controls. We saw no differen-
tial targeting capacity between miR-222 isoforms, indicat-
ing differential effects are not likely mediated through a dif-
ference in the general post-transcriptional targeting capac-
ities of the isomiRs (Figure 3F). Consistent with the previ-
ous data (Figure 2B and Supplementary Figure S2), a range
of miR-222 mimics possessing variable 3′ extensions all dis-
played similar repressive capacity on representative miR-
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Figure 1. Endogenous miRNAs exhibit substantial 3′ variation. (A) Frequency of miR-222 mapping reads are shown from multiple independent AGO-
CLIPs in MDA-MB-231 and SHEP cells. The sequence and abundance of canonical miR-222 from miRbase is shown. (B) Extensive miR-222 3′-
heterogeneity is also seen in publicly available whole cell RNA sequencing from three cell lines. (C and D) The distribution of 5′ and 3′ variants of all
miRNAs classified by distance from the most common end is shown by box plot. Shaded areas and whiskers indicate the 25–75th and 5–95th percentile
ranges respectively. Data were obtained from (C) AGO-bound miRNAs from MDA-MB-231 cells and (D) the most abundant 227 miRNAs from the
Cancer Genome Atlas (TCGA).
222-responsive 3′UTR target gene reporters (Supplemen-
taryFigure S3).Combinedwith the fact that longer isomiRs
are still capable of binding AGO (Figure 1A and C), these
data suggest differential effects are unlikely to result from
differences in the basic functional properties of miRNAs
such as stability, AGO-loading or generalized target selec-
tion.
Longer miR-222 isomiRs induce apoptosis
To further investigate the cell death caused by the expres-
sion of longer miR-222 isomiRs we performed flow cy-
tometry to evaluate the proportion of non-viable cells after
transfection. Consistent with morphological observations,
progressively longer miR-222 isomiRs displayed a progres-
sively stronger tendency to promote cell death, from 17%
by miR-222, to 42% by miR-222CUCU (Figure 4A). Once
again, miR-222GAGA (Figure 2B), exhibited an identical
activity to that of miR-222CUCU, again suggesting apop-
tosis was a function of length and not sequence. In fur-
ther confirmation of apoptotic cell death, miR-222CUCU-
transfected cells displayed cleavage of both caspase 3 and
PARP and prolonged activation of the apoptosis-promoter
Puma (BBC3) 72 h post-transfection (Figure 4B). Further,
both apoptosis promoters Puma andNoxa were specifically
upregulated at the RNA level by miR-222CUCU (Figure
4C). Collectively, these observations indicate the trigger-
ing of the intrinsic apoptosis pathway upon expression of
longer miR-222 isomiRs.
The differential apoptotic activity of longer 222 isomiRs is
not attributable to interferon responses
Longer double-stranded (ds-) RNAs are known to trig-
ger an interferon immune response, evolved as a defen-
sivemechanism against viral infection (53). Recently, longer
double-stranded miRNA mimics were reported to inhibit
cell proliferation and induce apoptosis independent of the
seed sequence through the activation of an interferon re-
sponse (54). Throughout our work, the inclusion of a size-
matched 25 nt ds-negative control (nc25) failed to elicit
anti-proliferative or pro-apoptotic responses which argues
against a non-specific interferon response as a mechanism
to explain the activities of miR-222CUCU. To further con-
firm this however, we performed RT-PCR of 21 key IFN-
responsive genes and observed no activation after the trans-
fection of any miR-222 isoform. A double-stranded posi-
tive control (siBlunt27) which promotes an interferon re-
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Figure 2. Longer miR-222 isomiRs alter cell morphology. (A and B) MCF10A cells are shown 72 h after the transfection of miR-222 isomiRs, the 21 or
25 nt controls (nc21 and nc25) or the miR-222GAGA mimic (in B). (C) Representative images of similarly transfected additional cell lines.
sponse through direct interactionwithRIG-1 (retinoic acid-
inducible gene 1) (55) successfully promoted the expression
of the majority of these genes (Figure 5). A matched nega-
tive control (siBlunt27+2), known to not elicit an interferon
response, accordingly failed to induce IFN-responsive gene
expression (56).
Unfortunately, due to the high sequence similarity be-
tween miR-222 isomiRs, we are not able to inhibit them
differentially, nor are we able to guide the cell to pro-
cess certain miR-222 isomiRs over others by the construc-
tion and transfection of exogenous miRNA expression vec-
tors. We did however recapitulate the effects of double-
stranded miR-222 mimics from two separate sources (Am-
bion and GenePharma, data not shown). As interferon re-
sponses are triggered by the engagement of different cell
surface receptors by RNAs of different size and structure,
we sought to further test the separate functions of miR-
222 isomiRs through the application of single-stranded
(ss-) miRNA mimics, offering an alternate overexpression
model and, presumably, the potential to engage different
interferon pathways. These mimics re-capitulated previous
observations, indicating reduced proliferation by all miR-
222 isoforms and the specific promotion of apoptosis by
miR-222CUCU but not canonical (21 nt) miR-222 or size-
matched negative controls (Supplementary Figure S4).
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Figure 3. miR-222 and its isomiRs inhibit proliferation and share the same target recognition potential. (A–C) MCF10A cells were transfected as indicated
and proliferation assessed by (A) confluence, (B) CyQuant and (C) MTS assay. (D) Scratch wound closure assay was also performed after transfection,
though effects on proliferation versus migration are difficult to disentangle. (E) The expression of CDKN1A (p21) was determined at both the mRNA
and protein level, 48 and 72 h post-transfection of miR-222, miR-222CUCU and the negative controls. (F) Relative luciferase activity was measured for
25 putative and established miR-222 target genes by cloning the respective 3′UTRs downstream of the reporter gene and co-transfecting with miR-222
isoforms or negative controls as indicated. The parental vector was used as a negative control.
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Figure 4. Apoptosis is induced by longer miR-222 isomiRs. (A) The proportion of non-viable cells and the expression of apoptotic marker genes at the (B)
RNA and (C) protein level were determined after transfection of the miR-222 isoforms or 21 and 25 nt controls (nc21 and nc25).MiR-222CUCU-mediated
apoptosis is indicated by the induction of pro-apoptotic Puma and Noxa and the cleavage of Caspase 3 and PARP.
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Figure 5. Interferon response genes are not induced by miR-222 transfection. MiR-222 isomiRs, control RNAs (nc21 and nc25), a known inducer of the
interferon response (siBlunt27+0) or a non-inducing negative control (siBlunt27+2) were transfected into MCF10A cells and a series of IFN (interferon)
pathway markers measured by RT-PCR.
The PI3K-AKT pathway is inhibited by miR-222CUCU
In order to identify genes and pathways through which
miR-222 isomiRs might be exerting differential functions,
mRNA-sequencingwas performed onMCF10A cells trans-
fected with control (nc21 and nc25), miR-222 or miR-
222CUCU miRNA mimics. Among the genes upregulated
by both miR-222 and miR-222CUCU, there was a clear
and strong over-representation of gene ontology classes as-
sociated with the cell cycle and cell division (Supplemen-
tary Figure S5). There were also groups of genes differ-
entially regulated between the miR-222 isomiRs, including
cell signalling genes upregulated by the CUCU extended
isomiR and small molecule metabolic processes downregu-
lated by this samemiRNAmimic.We utilized IMPaLA (In-
tegratedMolecular Pathway Level Analysis) (57) to identify
genetic networks that are consistently modulated by miR-
222CUCU in comparison to miR-222 and found ECM-
membrane and integrin associated pathways were enriched,
consistent with the decreased adherence we observe in miR-
222CUCU transfected cells prior to apoptosis. We also
identified that components of a number of signalling path-
ways (namely the PI3K-Akt component of larger EGFR
and TGF-B signalling networks) were enriched, which led
us to investigate PI3K-Akt cell survival signalling in greater
detail. We found that the expression of miR-222CUCU
downregulated the expression of a number of pathway
components, in sharp contrast to miR-222 which typi-
cally upregulated AKT-survival genes (Figure 6A). RT-
PCRandwestern blotting confirmedmany key components
(including PIK3CA, PIK3CB, PIK3R3, AKT1, AKT2 and
AKT3) were repressed upon miR-222CUCU transfection
(Figure 6B and C).
Among these genes, the AKT-regulator PIK3R3 (p55)
was of particular interest as it is strongly differentially reg-
ulated by different miR-222 isomiRs and its knockdown
phenocopied the effects of miR-222CUCU transfection in
four aspects: (i) siPIK3R3 inhibited the expression of key
PI3K-Akt genes, i.e. PIK3CA, PIK3CB, AKT1, 2 and 3
(Figure 6D and E); (ii) MCF10A cells displayed a bleb-
bing morphology and PARP cleavage indicative of apopto-
sis (Figure 6E and F); (iii) cell confluency was significantly
reduced after siPIK3R3 treatment (Figure 6F and G); and
(iv) siPIK3R3 induced cell death to a similar extent as miR-
222CUCU expression (Figure 6H).
The size of endogenous miRNAs correlates with their nuclear
localization
To further explore miR-222 isomiR differences, we sub-
jected our miR-222-affected gene expression profiles to
EISA (Exon-Intron Split Analysis) (58) to differenti-
ate genes regulated at the transcriptional and post-
transcriptional levels. Of the AKT-pathway genes that
are downregulated by miR-222CUCU, several (PIK3R3,
PIK3C2A, PIK3C2B) were downregulated primarily at the
transcriptional level (Supplementary Figure S6), suggest-
ing the possibility of non-canonical transcriptional silenc-
ing (59,60).
To investigate the possibility of direct transcriptional
regulation, nuclear and cytoplasmic compartments from
MCF10A cells were fractionated and the small RNA popu-
lation was sequenced. We observed abundant mature miR-
NAs within nuclei (Figure 7A), with specific miRNAs pref-
erentially enriched in one or the other cell compartment.
Clean fractionation was demonstrated by the respective nu-
clear and cytoplasmic enrichment of snoRNAs and tRNAs
respectively (Figure 7A) and through qPCR of known nu-
clear and cytoplasmic RNAs (Supplementary Figure S7).
Although we did not observe any specific sequences corre-
lating with sub-cellular localization (in keeping with some
reports (61,62) but in disagreement with others (63)), we
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Figure 6. Longer miR-222 isomiRs suppress the PIK3/AKT pathway. (A–C) The expression of multiple PIK3/AKT pathway components in MCF10A
cells in response to the transfection of miR-222 and miR-222CUCU are shown using (A) RNA sequencing, (B) qPCR or (C) western blotting. (D and E)
PI3KR3 knockdown decreases PI3K/AKT pathway gene expression and promotes apoptosis as indicated by (E) PARP cleavage, (F) morphology, (G) cell
confluence and (H) flow cytometry analysis for non-viable cells.
found a strong relationship between the size of endogenous
miRNAs and their sub-cellular location. On a global scale,
we observed a clear size-dependent trend for the nuclear en-
richment of both shorter (<19 nt) and longer (>23 nt) miR-
NAs compared to miRNAs of typical 20–22 nt size (Figure
7B). With regard to endogenous miR-222, there was a dra-
matic nuclear enrichment of miR-222 isomiRs of >23 nt in
size (Figure 7C), corresponding to the same isomiRs that
promote apoptosis.
DISCUSSION
It is suggested that miR-222 is a valuable biomarker for
cancer and cardiovascular disease (64,65) and its role
as a regulator of such processes as proliferation, apop-
tosis, chemoresistance and epithelial-mesenchymal tran-
sition have been extensively examined (64–71). Despite
this, the response of cells to miR-222 perturbation varies
widely. Anti-apoptotic roles for miR-222 are often reported
(20,72–86), with many of these studies also observing
pro-proliferative (66,73,75,76,79–82,84,85,87–95) and pro-
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Figure 7. Endogenous miRNAs are abundant within the nucleus and exhibit size-dependent nuclear enrichment. (A) MCF10A cells were separated into
nuclear and cytoplasmic fractions and subjected to Illumina sequencing. Clean fractionation is indicated by the differential localization of nuclear snoRNAs
and snRNAs and cytoplasmic tRNAs. Endogenous, mature miRNAs are both nuclear and cytoplasmic. The y-axis indicates total sequencing read counts
and the x-axis, length of the associated small RNA. (B) Shorter (<20 nt) and longer (>23 nt) miRNAs are preferentially enriched within nuclei. (C)
Proportion of the nuclear distribution of miR-222 isomiRs of varying size are indicated by box plot.
invasion/migration (73–76,80–82,85,87,89,90,94,96,97) ef-
fects. In direct contrast, pro-apoptotic effects (as we re-
port here with the transfection of longer miR-222 isomiRs)
are also observed (45,98–100). For reasons that remain to
be defined, cell-specificity accounts for at least some of
these differences, with varying effects on proliferation and
chemosensitivity reported between different lung cancer cell
lines in the same study (49). We speculate that differen-
tial functions of miR-222 isomiRs might also contribute to
these apparently contradictory findings, as we demonstrate
isomiR-specific effects on apoptosis and regulation of the
AKTpathwaywithin the one cell line. Very few studies spec-
ify the sequence of the transfected miRNA mimics, though
it is noteworthy that of those which do, all utilize miR-222
mimics that correspond to the canonical 21 nt form, and
all of these report anti-apoptotic effects (75,83,84,90)––in
direct contrast to our findings using longer isomiRs.
MiRbase, a reference sequence repository for miRNAs,
changed the canonical definition of human miR-222 in
version 10 (August 2007) from the +CUC containing se-
quence to the shorter and less abundant 21 nt sequence still
annotated today. Species-specific discrepancies also exist,
with the shortened 21 nt version representing the canon-
ical miR-222 sequence in most mammalian species (hu-
man, mouse, rat, cow, etc.), whilst in other species (spi-
der monkey, zebrafish, chicken), it is the +CUC isomiR
which is canonical. This has directly informed the produc-
tion of Taqman (Applied Biosystems) qPCR probes, with
human (shorter, RT002276) probes able to equally detect
all major human miR-222 isomiRs (21 nt, +CU, +CUC,
+CUCU), whilst probes designed against spider monkey
miR-222 (+CUC, RT000525) preferentially detect the hu-
man +CUCU isomiR but completely fail to detect the
shorter 21 nt canonical form (data not shown). Species-
specific miR-222 annotation and the version of mirBase
used for reference may therefore have a major effect on the
isomiR of miR-222 that is both capable of being detected
and that is chosen for use in expression studies. These dif-
ferences in turn may have significant consequences for the
investigation of miR-222 functional roles.
Although we have focused exclusively on the differential
effects of miR-222 isomiRs, it is noteworthy that more than
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half of all endogenously expressed miRNAs vary in the se-
quence or position of their 3′ terminus. Our work suggests
3′ variance may have a wider effect on the diversification of
miRNA function than has been previously thought, with
functional consequences of 3′ variance having received lit-
tle attention as it is removed from the 5′ ‘seed-site’ which is
responsible for the majority of miRNA–target interaction.
It has been reported that the transfection of longer
miRNA mimics (23 nt in size) decreases cell confluency
and promotes apoptosis, in conjunction with the upreg-
ulation of interferon pathway genes and PARP cleavage
(54). This occurred in response to both the length of the
miRNAmimic, and the seed-sequence of the co-transfected
passenger strand, and suggests that miRNA transfection
can promote cell death non-specifically as a result of in-
terferon pathway activation. We conclude that the phe-
nomenon we report here is not a length-dependent inter-
feron response for several reasons. All assays were accom-
panied by co-transfection with size-matched (21 and 25 nt)
negative control miRNA mimics which behaved identically
to each other with regard to cell morphology, confluency,
survival, apoptosis and the expression of the apoptosis and
AKT-associated proteins that we examined. Further, it was
reported that the triggering of interferon-associated apop-
tosis was accompanied by the upregulation of key interferon
pathway genes such as IFNB1, OAS1/OAS 2, CXCL10,
IFITM1 and RIG1, but none of these genes were induced
by any miR-222 isomiR or size-matched control sequence
in our work, though they were strongly upregulated by the
transfection of a positive control––a double stranded 27-
nt sequence known to activate the interferon pathway. Fur-
ther, the contribution of the passenger strand sequence is
discounted by the capacity of single stranded longer miR-
222 isomiRs to also trigger apoptosis.
Despite the markedly different outcome of miR-222
isomiR expression with regard to survival, most effects of
miR-222 and miR-222CUCU are in fact common between
isoforms. All isoforms inhibited cell proliferation and lu-
ciferase assays designed to examine the effect of miR-222
variation on canonical target genes, failed to demonstrate
any functional differences between short and long isomiRs.
This strongly argues against standard canonical targeting,
or other generalized properties such as AGO loading or
stability, as likely explanations for these differential effects.
Mutation of the 3′-extended nucleotides also had no ef-
fect on the capacity of longer miR-222 isomiRs to pro-
mote apoptosis, indicating differential effects occur in a
size and not-sequence dependent manner. The response of
the pro-survival PI3K-AKT signalling pathway; however,
was vastly different between isoforms, with miR-222 up-
regulating the expression of many components whilst miR-
222CUCU downregulated expression, not only of PI3KR3
whose knockdown phenocopied miR-222CUCU, but also
of many other signalling components as well.
We also find that longer miRNAs display an increased
proclivity for nuclear localization. This is true for both
endogenous miRNAs globally, and miR-222 specifically,
where we observe a marked increase in the relative nu-
clear localization of endogenous miR-222 isomiRs >23
nt in length. Although AGO and RISC-associated pro-
teins, along with an abundance of endogenous mature miR-
NAs, have been observed within the nuclei of various cells
(61,62,101–105), the functional significance of these obser-
vations are often unclear. Nuclear roles for AGO, miRNAs
and their isomiRs that are present within nuclei, include
well established examples in both the positive and nega-
tive regulation of transcription and alternative splicing (re-
viewed in (59,60,106–108)). AGO, bound to small RNAs
other than miRNAs, also has additional nuclear functions
including DNA damage repair (small RNAs produced at
sites of UV-induced DNA damage) (109,110), RNA pro-
cessing (3′ tRNA trailer sequences) (111) and regulating nu-
cleosome occupancy (small RNAs produced proximal to
transcription start sites) (112,113).
Much as there remains uncertainty regarding the func-
tion of nuclear miRNAs, the mechanisms that govern nu-
clear import/retention are also unclear and there is little
consensus between the identity of nuclear enriched miR-
NAs between studies. One early study reported a hexanu-
cleotide motif at the 3′ terminus of miR-29b that governs
its nuclear import (63), which was partially supported by
the identification of a related 3′ A(C/G)U(C/G) motif that
was over-represented within nuclear localized miRNAs in
neural stem cells (102). Post-transcriptional 3′ guanylation
was also reported to promote nuclear localization (61). Vir-
tually all studies however fail to support the conclusions of
others regarding factors that contribute to nuclear localiza-
tion. Similarly, we find no sequence motifs that are enriched
within nuclear localized miRNAs in MCF10A cells. Our
observation of size-dependent nuclear enrichment however
is supported by a separate study that also examines the sub-
cellular distribution of endogenous miRNAs within breast
cancer cells (MCF7,MCF10A,MDA-MB-231), that found
a progressive nuclear enrichment of longer miRNAs (101).
Although 3′ variance has been associated with miRNA
stability (reviewed in (21)) in both plants and animals, in
each of these reports 3′ variance has involved 3′-tailing
whereby nucleotides (mostly A and U) are added in a non-
templated manner. This is the first report (to our knowl-
edge) detailing functional consequences for differential pro-
cessing of the miRNA hairpin. Given the extensive 3′ vari-
ability that exists with miRNAs leading to a variety of en-
dogenous miRNA sizes, this work strongly suggests more
careful consideration be given to the effects of 3′ variance
andmore careful reporting be detailed in future studies with
regard to the sequence of the miRNA isoform being exam-
ined. It also highlights the potential importance of miRNA
size in regulating nuclear uptake and/or retention, which
may not only deplete the cytoplasmic pool of functional
miRNAs, but which may actively take on additional func-
tions.
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